In a major step towards enhancing rural healthcare, the government has approved an expansion of the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP), a scheme dedicated to providing affordable generic medicines across India. The initiative, launched by the Department of Pharmaceuticals, aims to establish more Jan Aushadhi Kendras (JAKs) in rural areas, thereby increasing access to essential medicines at significantly reduced prices.
Expansion of Jan Aushadhi Kendras:
The PMBJP scheme, which has already set up over 9,400 Jan Aushadhi Kendras nationwide, is set for further expansion. The government has outlined a target to open 2,000 new Kendras in Primary Agricultural Credit Societies (PACS) by December 2024. Of these, 1,000 Kendras are expected to be operational by August 2024. This expansion will cover 651 districts across India, with applications now being accepted online for establishing new JAKs.
Benefits of the PMBJP Scheme:
The PMBJP scheme brings several significant benefits to rural communities:
– Affordable Medicines: One of the primary advantages of the scheme is the provision of generic medicines at a fraction of the cost of branded drugs. PMBJP medicines are priced 50-90% lower, making essential medicines more accessible to rural residents.
– Economic Opportunities: The establishment of Jan Aushadhi Kendras in PACS is expected to boost income for these credit societies. Additionally, the initiative is anticipated to create new job opportunities in rural areas, contributing to local economic development.
Data Insights:
The PMBJP scheme has shown considerable progress and has ambitious plans for future growth:
– Target for Kendras: The government aims to open 2,000 PMBJKs in PACS by December 2024, with 1,000 Kendras expected to be functional by August 2024.
– Existing Kendras: There are currently over 9,400 PMBJKs operational across the country.
– Medicine and Device Availability: Jan Aushadhi Kendras offer a wide range of over 1,800 medicines and 285 medical devices.
– Eligibility and Financial Incentives : Individuals with D.Pharma/B.Pharma qualifications or organizations with appointed D.Pharma/B.Pharma degree holders can apply to open a Jan Aushadhi Kendra. The government provides a financial incentive of ₹5 lakh per Kendra, capped at ₹15,000 per month. Special categories and areas are eligible for an additional one-time incentive of ₹2 lakh for IT and infrastructure expenses.
Growth and Future Expansion:
The PMBJP scheme has witnessed remarkable growth since its inception:
– Sales Milestone: This year, the scheme achieved a sales milestone of ₹1,000 crore, reflecting increased public adoption of generic medicines.
– Expansion Since 2014: The number of Jan Aushadhi Kendras has grown over 100-fold since 2014, with nearly 10,000 Kendras now in operation.
– Future Plans : Looking ahead, the government aims to expand the network to 25,000 Jan Aushadhi Kendras by March 2026.
The expansion of the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana represents a significant step forward in improving healthcare accessibility in rural India. By increasing the number of Jan Aushadhi Kendras and providing affordable medicines, the initiative addresses a critical need in rural healthcare. Continued growth of the scheme will depend on raising public awareness about the benefits of generic medicines and ensuring the efficient operation of these Kendras.
